» Articles » PMID: 12966526

Left-sided CHILD Syndrome Caused by a Nonsense Mutation in the NSDHL Gene

Overview
Specialty Genetics
Date 2003 Sep 11
PMID 12966526
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Congenital hemidysplasia with ichthyosiform nevus and limb defects (CHILD) syndrome is a rare X-linked dominant malformation syndrome characterized by unilaterally distributed ichthyosiform nevi, often sharply delimited at the midline, and ipsilateral limb defects. At least two-thirds of cases demonstrate involvement of the right side. Mutations in an essential enzyme of cholesterol biosynthesis, NAD(P)H steroid dehydrogenase-like [NSDHL], have been reported in five unrelated patients with right-sided CHILD syndrome and in a sixth patient with bilaterally, symmetric nevi and mild skeletal anomalies, but not with CHILD syndrome as originally defined. Although all of the molecularly diagnosed cases with the CHILD phenotype to date have had right-sided disease, we report here a novel nonsense mutation (E151X) of NSDHL in an infant with left-sided CHILD syndrome. This result demonstrates that both right- and left-sided CHILD syndrome can be caused by mutations in the same gene.

Citing Articles

Etiological identification of recurrent male fatality due to a novel NSDHL gene mutation using trio whole-exome sequencing: A rare case report and literature review.

Zhuang J, Luo Q, Xie M, Chen Y, Jiang Y, Zeng S Mol Genet Genomic Med. 2022; 11(3):e2121.

PMID: 36504312 PMC: 10009909. DOI: 10.1002/mgg3.2121.


A novel NSDHL variant in CHILD syndrome with gastrointestinal manifestations and localized skin involvement.

Tan E, Chia S, Rafiee K, Lee S, Kwek A, Tan S Mol Genet Genomic Med. 2021; 10(1):e1848.

PMID: 34957706 PMC: 8801147. DOI: 10.1002/mgg3.1848.


Novel variant in NSDHL gene associated with CHILD syndrome and syndactyly- a case report.

Hettiarachchi D, Panchal H, Lai P, Dissanayake V BMC Med Genet. 2020; 21(1):164.

PMID: 32819291 PMC: 7439548. DOI: 10.1186/s12881-020-01094-y.


Endogenous Sterol Metabolites Regulate Growth of EGFR/KRAS-Dependent Tumors via LXR.

Gabitova L, Restifo D, Gorin A, Manocha K, Handorf E, Yang D Cell Rep. 2015; 12(11):1927-38.

PMID: 26344763 PMC: 4581991. DOI: 10.1016/j.celrep.2015.08.023.


Targeting C4-demethylating genes in the cholesterol pathway sensitizes cancer cells to EGF receptor inhibitors via increased EGF receptor degradation.

Sukhanova A, Gorin A, Serebriiskii I, Gabitova L, Zheng H, Restifo D Cancer Discov. 2012; 3(1):96-111.

PMID: 23125191 PMC: 3546138. DOI: 10.1158/2159-8290.CD-12-0031.